Which is better in Georgia assisted reproductive hospital? Selection of hospitals in Tbilisi and suggestions for treatment

Which is better in Georgia assisted reproductive hospital? Selection of hospitals in Tbilisi and suggestions for treatment

When preparing to go to Georgia for assisted reproductive treatment, many families will first search for "which is better in Georgia's assisted reproductive hospital". However, after entering the consultation stage, it will be found that even in the same city, there are differences in diagnosis and treatment items, laboratory conditions, doctor teams and charging methods in different hospitals.

For families who are at risk of infertility, repeated transplant failure or genetic diseases, choosing a hospital is not only to find a well-known institution, but also to judge whether it can solve their current fertility problems.

What assisted reproductive hospitals in Georgia are worth knowing?

Georgia's assisted reproductive medical resources are mainly concentrated in Tbilisi, the capital, and the following institutions can be used as the objects of preliminary understanding.

ReproART reproductive medicine center

ReproART is a reproductive medicine institution established in 2012, with a medical center in Tbilisi and branches in other cities in Georgia. Its public services include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), male fertility test and embryo genetics test.

For families with male fertility problems or who need to further assess the genetic risk of embryos, we can find out whether this institution has the corresponding diagnosis and treatment ability.

GGRC Georgia-Germany Reproductive Center

GGRC is located in Tbilisi. Its public business involves IVF and related reproductive medical services, and it also has international patient reception experience.

Families who want to understand the overseas medical treatment process through Chinese communication can be included in the consultation list, but the actual doctor, treatment place and specific service scope need to be confirmed.

INNOVA reproductive medicine center

INNOVA is also located in Tbilisi, and its public information involves services such as in vitro fertilization and embryo genetic testing.

During the consultation, we can focus on whether the laboratory directly undertakes the embryo culture work, how the attending doctor makes the treatment plan, and which laboratories complete the testing items.

Chachava Clinic maternity hospital

Chachava is a medical institution with a background in obstetrics and gynecology, with reproductive health-related services.

If the patient has gynecological diseases at the same time, or wants to know how to link reproductive therapy with follow-up obstetrics and gynecology medical care, he can further investigate his relevant departments and admission conditions.

Each of the above institutions has its own business characteristics, but it is not possible to determine which hospital has a higher success rate just by public introduction. In the end, it is still necessary to make a choice through medical evaluation and institutional data verification.

Before comparing hospitals, rule out three situations.

Many families are used to contacting multiple hospitals for inquiry at the same time. In fact, a more effective method is to determine which institutions do not meet their own needs first.

The first type: the subject of medical responsibility cannot be clearly stated.

Some overseas medical services involve multiple institutions, and the consultants may be different from the medical institutions that actually carry out egg retrieval, embryo culture and transplantation.

Therefore, we should confirm the official name of the hospital, the actual treatment address, professional qualifications, and the responsibility attribution after medical problems.

The second type: only provide successful cases without explaining medical conditions.

Older women, patients with decreased ovarian reserve and patients with repeated transplant failure face different clinical problems.

If the hospital only shows successful cases, but does not evaluate them in combination with age, AMH, previous treatment history and other examination results, it is difficult to judge whether the scheme is suitable for them.

In particular, it should be noted that the clinical pregnancy rate and the live birth rate are not the same index, and the data under different statistical calibers cannot be directly compared.

The third type: the quotation looks complete and the actual cost boundary is unclear.

Overseas test-tube therapy may involve examination, drug excretion, egg retrieval, laboratory operation, embryo detection, preservation and transplantation.

Some quotations only include the basic medical stage, and the follow-up treatment may incur additional expenses. When choosing a hospital, a written list of items should be required to make clear which expenses are included and which items need to be paid separately.

According to different fertility conditions, the focus of hospital selection is also different.

If it is the first time for couples to consider IVF, they usually need to complete the basic fertility examination before judging whether they are suitable for IVF treatment cycle, instead of directly choosing the hospital with the most technical projects.

For women over 40 years old, the focus should be on ovarian reserve, physical condition, previous treatment results and individualized plans formulated by doctors. Age may affect the quantity and quality of eggs, which cannot be compensated by an assisted reproductive technology alone.

If one spouse has abnormal chromosome structure or a clear risk of genetic diseases, it should be further confirmed whether the hospital provides corresponding genetic counseling and embryo testing services, and understand the indications and limitations of testing.

For patients who have failed in repeated treatment, doctors should look for possible reasons based on previous embryonic development, uterine conditions and treatment records, rather than simply repeating the previous plan.

What other questions need to be confirmed when going to Georgia for medical treatment?

In addition to medical conditions, cross-border treatment also involves medical qualifications, data preparation and itinerary arrangement.

Article 143 of Georgia's Health Care Law stipulates in vitro fertilization and related assisted reproduction, but the applicable conditions involved in different treatment paths are not exactly the same.

Therefore, before making an appointment, the hospital and local professional legal personnel should confirm whether the specific project meets the current regulations, and it is not allowed to carry out a certain type of assisted reproductive project, which is understood as all applicants meet the conditions.

Before the actual visit, it is recommended to prepare the previous examination results, surgical records, medication plans and records of assisted reproductive treatment, and ask in advance which examinations need to be re-completed.

In addition, it should also be confirmed whether the doctor can continue to follow up the treatment, whether the translation service covers important medical communication, and how to connect the examination and follow-up after returning home.

How to choose Georgia Assisted Reproductive Hospital?

If there is a clear medical demand, it is recommended to give priority to hospitals that can provide targeted diagnosis and treatment programs, whose medical qualifications can be verified and whose cost terms are clear.

Institutions such as ReproART, GGRC, INNOVA and Chachava can be the objects of early understanding, but no hospital can be suitable for all patients.

When comparing assisted reproductive hospitals in Georgia, the most valuable thing is not to find a unified ranking, but to communicate with different doctors with their own test results, and then make a decision according to medical ability, medical conditions, expenses and legality.

Choosing a suitable hospital should start from the real medical needs, not from the success rate or price in publicity.